NKTR — Nektar Therapeutics
Unknown Industry · Unknown Sector
Nektar Therapeutics is a research-based biopharmaceutical company dedicated to discovering and developing drugs in areas of unmet medical need. Its research and development pipeline of new investigational medicines includes oncology, immunology, and virology therapeutics. The company focuses on using novel chemistry approaches to create medicines for treating cancer and autoimmune diseases.
Industry Peers
—
Sector Peers
—
Key Facts
| Status | Active |
| Sector | Unknown Sector |
| Industry | Unknown Industry |
| Joined | 2018-03-19 |
| Tenure | 1 yrs |
S&P 500 Timeline
2018-03-19Joined S&P 500
2019-10-03Removed from S&P 500
Data source:
Wikipedia · CC BY-SA 4.0 · Updated 2026-07-10